In November 2025, the Australian Department of Veterans' Affairs (DVA) became the first government payer in the world to fund ...

On Tuesday, an expert panel advising the Food and Drug Administration (FDA) on the use of MDMA, or ecstasy, in combination with talk therapy to treat post-traumatic stress disorder rejected the ...

Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a major setback for groups seeking a breakthrough decision in favor of using mind-altering ...

A decades-long campaign to legalize MDMA as a mainstream medical treatment will reach a climax as soon as Friday, with the Food and Drug Administration poised to decide whether the psychedelic should ...

An FDA advisory panel has recommended that the agency not approve the use of MDMA-assisted therapy as a treatment for PTSD. A U.S. Food and Drug Administration advisory committee voted on Tuesday ...

Also known as molly or ecstasy, MDMA has the potential to treat post-traumatic stress disorder (PTSD). But psychedelic-assisted therapy can only be administered by a trained professional. Without the ...

A panel of experts advising the U.S. Food and Drug Administration (FDA) voted against adopting MDMA as a treatment for post-traumatic stress disorder (PTSD) on Tuesday. Members of the FDA’s ...

In a show of bipartisanship, 80 members of Congress from both sides of the aisle have united in letters urging President Joe Biden and the US Food and Drug Administration to further consider studies ...

VANCOUVER, BC, May 30, 2024 /PRNewswire/ - Numinus Wellness Inc. (NUMI:CA) ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative ...

The psychedelic drug MDMA could be approved for medical use to treat post-traumatic stress disorder following a federal regulatory meeting on Tuesday. MDMA, also known as molly or ecstasy, has been ...

Following a poor showing for Lykos Therapeutics’ MDMA candidate for post-traumatic stress disorder at a recent FDA advisory committee meeting, the other shoe has dropped. Friday, the FDA declined to ...

The FDA's decision on MDMA therapy for PTSD is imminent, impacting MindMed investors and the psychedelic medicine industry. An FDA advisory committee voted against approving MDMA therapy, causing ...